AUS
NZ
UK
CA
USA
IND
Highlights
Lindenwold Advisors INC decreased its stake in LeMaitre Vascular during the first quarter
Insider transaction activity includes a recent share by the CEO
Institutional firms continue to adjust positions in the healthcare equipment sector
LeMaitre Vascular, Inc. (NYSE:LMAT), which operates in the medical instruments space, recently saw a change in shareholder composition. Lindenwold Advisors INC reported a reduction in its position in the company during the first quarter, as reflected in its latest filing with the Securities & Exchange Commission.
Stake Reduction by Lindenwold Advisors INC
According to regulatory disclosures, Lindenwold Advisors INC decreased its shareholding in LeMaitre Vascular by a modest margin. The firm trimmed its overall exposure by disposing of a small number of shares during the first quarter. Following this adjustment, the total number of shares held by Lindenwold Advisors INC in LeMaitre Vascular saw a decrease from the prior reporting period.
Institutional Position Adjustments in LeMaitre Vascular
Alongside Lindenwold Advisors INC, several other asset management entities adjusted their allocations in LeMaitre Vascular. Summit Investment Advisors Inc. expanded its position slightly during the fourth quarter. Bank of Montreal Can also increased its exposure in the same timeframe, citing additional share accumulation.
Avantax Advisory Services Inc. adjusted its allocation in the first quarter, reflecting a small increase in shares held. Meanwhile, Fifth Third Bancorp made a slight upward revision to its existing stake. Cetera Investment Advisers also raised its position, increasing the number of shares in its portfolio. These actions reflect general portfolio rebalancing within the healthcare equipment industry, in which LeMaitre Vascular operates. A significant proportion of the company’s ownership remains with asset managers and institutional firms.
Executive-Level Share Transactions
In corporate-related transactions, CEO George W. Lemaitre executed a share involving a limited number of company shares. The reported via official filings submitted to the Securities & Exchange Commission. Following, the executive retained a majority of his equity interest in the firm. Total transactions from insiders over the past three months include further disposals, reflecting changes in internal equity allocations.
Shareholder Composition and Insider Activity Overview
As of the latest reports, a large percentage of LeMaitre Vascular shares continue to be held by institutional entities. The remaining portion is held by individuals associated with the company. Public records indicate that insider transactions, such as the ones recently conducted, are documented in compliance with regulatory disclosure standards.
LeMaitre Vascular’s Placement in the NASDAQ Index
LeMaitre Vascular is listed under the NASDAQ Index, aligning it with a broad spectrum of firms within the healthcare and medical device industry. The index tracks companies across various innovation-driven sectors, including healthcare technology and equipment manufacturing. LMAT's continued presence on this platform places it within a high-visibility exchange tier for the medical device domain.
Frequently Asked Questions
- What industry does LeMaitre Vascular belong to?
LeMaitre Vascular operates in the medical instruments and healthcare equipment industry. - Where is LeMaitre Vascular listed?
The company is listed on the NASDAQ index under the ticker symbol LMAT. - Are there recent insider transactions at LeMaitre Vascular?
Yes, recent filings show executive-level share sales within the past quarter.
